1-11 of 11
Kwee L Yong, MBChB, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Whole Body (WB) MRI in Newly Diagnosed Multiple Myeloma (MM): Fat Fraction Changes at 8 Weeks Predict Response to Induction with Bortezomib Regimens

Free
Arash Latifoltojar, MB BS, MSc, MPhil, Kwee L Yong, MBChB, PhD, Margaret Hall-Craggs, BA, MB BS, MD, Neil Rabin, MB,BS, PhD, Rakesh Popat, MBBS, PhD, Alan Bainbridge, Magdalena Sokolska, Nikolaos Dikaios, Shirley D'Sa, MD FRCP, FRCPath, Ali Rismani, MBBS, Shonit Punwani, Mb BS, BSc, PhD
Journal: Blood
Blood (2015) 126 (23): 1850.
https://doi.org/10.1182/blood.V126.23.1850.1850
Published: 2015
Journal Articles

Bortezomib (Velcade), Thalidomide, Dexamethasone and Panobinostat (VTD-P) Is a Safe, Well Tolerated and Efficacious Regimen for Patients with Relapsed Multiple Myeloma: Preliminary Results of the Muk-Six Trial

Free
Rakesh Popat, MBBS, PhD, Sarah R Brown, Louise M Flanagan, Andrew Hall, Bhuvan Kishore, MBBS, FRPATH, MRCP, Matthew Streetly, Heather E Oakervee, Simon L. Hallam, Matthew Smith, MBBS, MA, MRCP, MRCPath, MD, Kwee L Yong, MBChB, PhD, Gordon Cook, MD PhD, James D. Cavenagh, MD
Journal: Blood
Blood (2015) 126 (23): 1826.
https://doi.org/10.1182/blood.V126.23.1826.1826
Published: 2015
Journal Articles

Carfilzomib, Cyclophosphamide and Dexamethasone Is Well Tolerated in Patients with Relapsed/Refractory Multiple Myeloma Who Have Received One Prior Regimen

Free
Kwee L Yong, MBChB, PhD, Sarah Brown, Samantha Hinsley, Louise Flanagan, Neil Rabin, MB,BS, PhD, Karthik Ramasamy, Jamie Cavenagh, Roger G Owen, Martin F Kaiser, MD, Eric Low, Catherine Williams
Journal: Blood
Blood (2015) 126 (23): 1840.
https://doi.org/10.1182/blood.V126.23.1840.1840
Published: 2015
Journal Articles

Outcomes Following Salvage Autologous Stem Cell Transplant (ASCT2) Vs Low Dose Alkylating Consolidation Therapy Following Bortezomib-Containing Re-Induction for Relapsed Multiple Myeloma (MM) May be Dependent on Age and Symptomatic Status Initiation of Re-Induction: Results from the Myeloma X (Intensive) Trial

Free
John Ashcroft, MD MBBChir, PhD MRCP, MA, FRCPath, David A Cairns, Cathy Williams, A Hockaday, J. D. Cavenagh, MD MRCP, John A Snowden, MD FRCP, FRCPath, Christopher Parrish, MD, Kwee L Yong, MBChB, PhD, Jim Cavet, FRCPath, Hannah Hunter, Jennifer Bird, Guy Pratt, MD, Sally Chown, Earnest Heartin, Sheila J.M. O'Connor, Julia Brown, PhD, Curly Morris, MD, Gordon Cook, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1981.
https://doi.org/10.1182/blood.V126.23.1981.1981
Published: 2015
Journal Articles

A Salvage Autologous Stem Cell Transplant (ASCT2) Induces Superior Overall Survival Following Bortezomib-Containing Re-Induction Therapy for Relapsed Multiple Myeloma (MM): Results from the Myeloma X (Intensive) Trial

Free
Gordon Cook, MD PhD, Cathy Williams, David A Cairns, Anna Hockaday, Jamie Cavenagh, John A Snowden, MD FRCP, FRCPath, Christopher Parrish, MD, Kwee L Yong, MBChB, PhD, Jim Cavet, FRCPath, Hannah Hunter, Jennifer Bird, Guy Pratt, MD, Sally Chown, Earnest Heartin, Sheila J.M. O'Connor, John Ashcroft, MD MBBChir, PhD MRCP, MA, FRCPath, Julia Brown, PhD, Curly Morris, MD
Journal: Blood
Blood (2015) 126 (23): 394.
https://doi.org/10.1182/blood.V126.23.394.394
Published: 2015
Journal Articles

Patient-Reported Outcomes (PRO) in the Setting of Relapsed Myeloma: The Influence of Treatment Strategies and Genetic Variants Predict Quality of Life and Pain Experience

Free
Sam H Ahmedzai, MBChB BSc FRCP, John A Snowden, MD FRCP, FRCPath, Angela Cox, BA MA PhD, David A Cairns, Cathy D Williams, Anna Hockaday, Jamie Cavenagh, Christopher Parrish, MD, Kwee L Yong, MBChB, PhD, Jim Cavet, FRCPath, Hannah Hunter, Jennifer Bird, John Ashcroft, MD MBBChir, PhD MRCP, MA, FRCPath, Julia Brown, PhD, Curly Morris, MD, Gordon Cook, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3180.
https://doi.org/10.1182/blood.V126.23.3180.3180
Published: 2015
Journal Articles

Subcutaneous PAD As Induction Therapy for Patients with Newly Diagnosed Myeloma: A Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Patients with Deferred Autologous Stem Cell Transplantation (PADIMAC)

Free
Rakesh Popat, James D Cavenagh, MD, Roger G Owen, MD, Matthew Streetly, Stephen A Schey, MD, Mickey Koh, MD, Josephine Crowe, Michael F. Quinn, FRCPath, MB, MD MRCP, Shirley D'Sa, MD FRCP, FRCPath, Andres Virchis, Gordon Cook, MD PhD, Charles Crawley, Guy Pratt, Mark Cook, PhD FRCPath, Heather E. Oakervee, MBBS, BSc, MD MRCP, FRCPath, Nicholas Counsell, Toyin Adedayo, Alison Evans, Nivette Braganca, Paul Smith, MSc, Janet lyons-Lewis, Neil Rabin, Kwee L Yong, MBChB, PhD
Journal: Blood
Blood (2014) 124 (21): 4745.
https://doi.org/10.1182/blood.V124.21.4745.4745
Published: 2014
Journal Articles

Cell Cycle Responses of Cyclin D1 and D2-Bearing Multiple Myeloma Tumours to DNA Damage Caused By Ionising Radiation

Free
Dean Smith, MBBS, Kwee L Yong, MBChB, PhD, David Mann, PhD
Journal: Blood
Blood (2014) 124 (21): 2011.
https://doi.org/10.1182/blood.V124.21.2011.2011
Published: 2014
Journal Articles

Synergistic Induction of Cell Death By Combined Inhibition of PIM and AKT Kinases in Cytogenetically Defined Standard and High-Risk Multiple Myeloma

Free
Koremu Meja, Dean Smith, MBBS, Laura Percy, Dennis Huszar, PhD, Barry R Davies, Kwee L Yong, MBChB, PhD, Asim Khwaja
Journal: Blood
Blood (2014) 124 (21): 4723.
https://doi.org/10.1182/blood.V124.21.4723.4723
Published: 2014
Journal Articles

Global Methylation Analysis of Cyclin D1vs D2 Dysregulated Primary Myeloma Samples

Free
Jonathan I Sive, MBChB, Andrew Feber, PhD, Dean Smith, MBBS, John Quinn, MB, PhD, Stephan Beck, PhD, Kwee L Yong, MBChB, PhD
Journal: Blood
Blood (2014) 124 (21): 3389.
https://doi.org/10.1182/blood.V124.21.3389.3389
Published: 2014
Journal Articles

Cohort Analysis of FISH Testing of CD138+ Cells in Relapsed Multiple Myeloma: Implications for Prognosis and Choice of Therapy

Free
Dean Smith, MBBS, Clemency Stephenson, Anna Lach, Steve Chatters, Helena Kempski, Kwee L Yong, MBChB, PhD
Journal: Blood
Blood (2014) 124 (21): 3399.
https://doi.org/10.1182/blood.V124.21.3399.3399
Published: 2014